Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system

被引:330
作者
Turenne, CY
Sanche, SE
Hoban, DJ
Karlowsky, JA
Kabani, AM
机构
[1] Ctr Hlth Sci, Dept Clin Microbiol, Winnipeg, MB R3A 1R9, Canada
[2] Ctr Hlth Sci, Dept Med, Winnipeg, MB R3A 1R9, Canada
[3] Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB R3T 2N2, Canada
[4] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada
[5] Royal Univ Hosp, Div Infect Dis, Saskatoon, SK S7N 0W8, Canada
关键词
D O I
10.1128/JCM.37.6.1846-1851.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive fungal disease often plays an important role in the morbidity and mortality of immunocompromised patients. The poor sensitivity of current fungal blood culture and histological practices has led to the development of highly sensitive and specific molecular techniques, such as the PCR. Sequence variability of the internal transcribed spacer 2 (ITS2) region of fungi is potentially useful in rapid and accurate diagnosis of clinical fungal isolates. PCR with fungus-specific primers targeted toward conserved sequences of the 5.8S and 28S ribosomal DNA (rDNA) results in amplification of the species-specific ITS2 regions, which are variable in amplicon length. We have made use of the ABI PRISM 310 genetic analyzer and the ABI PRISM 310 GeneScan analysis software for the determination of variable size differences of the ITS2 region of clinically important fungi, including Candida and non-Candida yeasts, Aspergillus species, and a variety of dermatophytes. No cross-reaction occurred when samples were tested against human and bacterial genomic DNA. We have found that most clinically significant fungal isolates can be differentiated by this method, and it therefore serves to be a promising tool for the rapid (<7 h) diagnosis of fungemia and other invasive fungal infections.
引用
收藏
页码:1846 / 1851
页数:6
相关论文
共 29 条
[1]   SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989 [J].
BANERJEE, SN ;
EMORI, TG ;
CULVER, DH ;
GAYNES, RP ;
JARVIS, WR ;
HORAN, T ;
EDWARDS, JR ;
TOLSON, J ;
HENDERSON, T ;
MARTONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S89
[2]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[3]   Detection and identification of fungal pathogens in blood by using molecular probes [J].
Einsele, H ;
Hebart, H ;
Roller, G ;
Loffler, J ;
Rothenhofer, I ;
Muller, CA ;
Bowden, RA ;
vanBurik, JA ;
Engelhard, D ;
Kanz, L ;
Schumacher, U .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1353-1360
[4]   Rapid identification of Candida species with species-specific DNA probes [J].
Elie, CM ;
Lott, TJ ;
Reiss, E ;
Morrison, CJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) :3260-3265
[5]  
Favero MS, 1996, AM J INFECT CONTROL, V24, P380
[6]  
FROMTLING RA, 1995, MANUAL CLIN MICROBIO, P697
[7]   MICROTITRATION PLATE ENZYME-IMMUNOASSAY TO DETECT PCR-AMPLIFIED DNA FROM CANDIDA SPECIES IN BLOOD [J].
FUJITA, SI ;
LASKER, BA ;
LOTT, TJ ;
REISS, E ;
MORRISON, CJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (04) :962-967
[8]   A CONTROLLED TRIAL OF FLUCONAZOLE TO PREVENT FUNGAL-INFECTIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].
GOODMAN, JL ;
WINSTON, DJ ;
GREENFIELD, RA ;
CHANDRASEKAR, PH ;
FOX, B ;
KAIZER, H ;
SHADDUCK, RK ;
SHEA, TC ;
STIFF, P ;
FRIEDMAN, DJ ;
POWDERLY, WG ;
SILBER, JL ;
HOROWITZ, H ;
LICHTIN, A ;
WOLFF, SN ;
MANGAN, KF ;
SILVER, SM ;
WEISDORF, D ;
HO, WG ;
GILBERT, G ;
BUELL, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :845-851
[9]   CLINICAL-FEATURES AND ANALYSIS OF RISK-FACTORS FOR INVASIVE CANDIDAL INFECTION AFTER MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
REED, EC ;
MORI, M ;
FISHER, LD ;
SKERRETT, S ;
DANDLIKER, PS ;
KLIS, B ;
COUNTS, GW ;
MEYERS, JD .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) :731-740
[10]  
KARLOWSKY JA, 1997, DIAGN MICROBIOL INFE, V28, P5